Ginecologa specialista in medicina della riproduzione e procreazione medicalmente assistita presso LIVET – Genera Torino.
Pubblicazioni:
– “Effect of a Combination of Myo-Inositol, Alpha-Lipoic Acid, and Folic Acid on Oocyte Morphology and Embryo Morphokinetics in non-PCOS Overweight/Obese Patients Undergoing IVF: A Pilot, Prospective, Randomized Study”, Journal of Clinical Medicine, 2020
– “Expectant management before in vitro fertilization in women aged 39 or above and unexplained infertility does not decrease live birth rates compared to immediate treatment”, Reproductive Sciences, 2022
– “Uterine Fibroids, from diagnosis to treatment” edizione Nova Medicine Health, 2021 nella sezione: “Impact, Management and treatment of Uterine Myomas in Infertile Couples”
– “Women in advanced reproductive age: are the follicular output rate, the follicle-oocyte index and the ovarian sensitivity index predictors of live birth in an IVF cycle?” Journal of Clinical Medicine, 2022
– “Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone”, Journal of Clinical Medicine, 2022
– “Management of Infertility” edizione Elsevier 2022 – capitolo: preparation of the couple for the ART technique: necessary and unnecessary tests.
Presentazione poster ESHRE – European Society of Human Reproduction and Embriology, 2020:
– “Ovarian Stimulation with rFSH+rLH vs. rFSH alone in poor/suboptimal/normal responders undergoing IVF: real life analysis of 1382 patients stratified for the number of retrieved oocytes”.
Relatrice al congresso SIFES e MR 2021 – Società Italiana di Fertilità e Sterilità e Medicina della Riproduzione, con l’abstract dello studio svolto in collaborazione con l’Università di Amsterdam UMC:
– “FORT (Follicular Output Rate), FOI (Follicle-Oocyte Index) E OSI (Ovarian Sensitivity Index) come fattori predittivi di Live Birth Rate in età materna avanzata”.
